Quarterly report pursuant to Section 13 or 15(d)

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? DEFICIT (Details)

v3.24.2.u1
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Increase (Decrease) in Stockholders' Equity        
Beginning balance $ (94,433) $ (82,535) $ (84,369) $ (143,737)
Beginning balance (in shares)     93,574,000  
Net loss (9,869) 113 $ (22,342) (8,190)
Foreign currency translation adjustments, net 1,465 1,480 994 (1,094)
Shares issued under employee incentive plans, net 0 0 0 0
Warrants issued in connection with debt refinancing     49  
Stock-based compensation $ 906 $ 2,981 $ 3,737 $ 8,340
Ending balance (in shares) 95,850,000 93,144,000 95,850,000 93,144,000
Ending balance $ (101,931) $ (77,963) $ (101,931) $ (77,963)
Stockholders' Equity, Period Increase (Decrease)   2,289   49,630
Scenario, Adjustment        
Increase (Decrease) in Stockholders' Equity        
Beginning balance   2,283   16,144
Common Stock        
Increase (Decrease) in Stockholders' Equity        
Beginning balance $ 956 $ 922 $ 936 $ 605
Beginning balance (in shares) 95,519,000 92,158,000 93,574,000 60,433,000
Shares issued under employee incentive plans, net $ 3 $ 6 $ 23 $ 20
Shares issued under employee incentive plans, net (in shares) 331,000 625,000 2,276,000 2,050,000
Ending balance (in shares) 95,850,000 93,144,000 95,850,000 93,144,000
Ending balance $ 959 $ 932 $ 959 $ 932
Stockholders' Equity, Period Increase (Decrease)   $ 10   $ 327
Stock Issued During Period, Shares, Period Increase (Decrease)   986,000   32,711,000
Additional Paid-in Capital        
Increase (Decrease) in Stockholders' Equity        
Beginning balance 705,230 $ 696,567 702,370 $ 624,805
Shares issued under employee incentive plans, net (3) (6) (23) (20)
Warrants issued in connection with debt refinancing     49  
Stock-based compensation 906 2,981 3,737 8,340
Ending balance 706,133 699,536 706,133 699,536
Stockholders' Equity, Period Increase (Decrease)   2,969   74,731
Accumulated Deficit        
Increase (Decrease) in Stockholders' Equity        
Beginning balance (798,567) (776,027) (786,094) (767,724)
Net loss   113 (22,342) (8,190)
Ending balance (808,436) (775,914) (808,436) (775,914)
Stockholders' Equity, Period Increase (Decrease)   (2,170)   (24,334)
Accumulated Deficit | Scenario, Adjustment        
Increase (Decrease) in Stockholders' Equity        
Beginning balance   2,283   16,144
Accumulated Other Comprehensive Loss        
Increase (Decrease) in Stockholders' Equity        
Beginning balance (2,052) (3,997) (1,581) (1,423)
Foreign currency translation adjustments, net 1,465 1,480 994 (1,094)
Ending balance $ (587) (2,517) $ (587) (2,517)
Stockholders' Equity, Period Increase (Decrease)   $ 1,480   $ (1,094)